Identification of genetically-supported new drug targets for osteomyelitis based on druggable genomes
{{output}}
Background: Limited drug treatment data are available for osteomyelitis (OM), an inflammatory bone condition secondary to infection. Given its genetic characteristics, it is necessary to integrate genetics into drug development f... ...
